Logo
S

Sirius Medical

51 employees

Sirius Medical is dedicated to improving care for cancer patients by delivery of unsurpassed, yet affordable solutions that enable precise and efficient removal of tumors. The company is a spin-off of the Netherlands Cancer Institute, where researchers recognized the need to simplify and improve localization technology for the surgical removal of breast cancers. This led to the development and clinical demonstration of the first magnetic seed localization, a technique that Sirius Medical perfected and further developed into the Sirius Pintuition System. Today, Sirius Pintuition represents the next generation of tumor localization technology, known as Surgical Marker Navigation. Pintuition is the only wire-free localization technology designed to provide navigational guidance in an easy-to-use and intuitive system. Its state-of-the-art GPSDetect™ software and unique TargetLOC™ feature provide real-time directional guidance using audio and visual feedback for unmatched precision to locate tumors more efficiently and accurately. The Pintuition platform is simple, precise, and accurate, delivering a better experience for patients and physicians. The CE-marked and FDA-cleared system is currently available in over 200 centers in the United States and western Europe. Don’t settle for localization….navigate with Pintuition.

Investor insights

Funding rounds participated in

$10M sweet spot round size

Investor type

Public Company

Basic info

Industry

Medical Equipment Manufacturing

Sectors

Medical Equipment Manufacturing

Date founded

2017

Funding rounds raised

Total raised

$10M

from 3 investors over 1 rounds

S

Sirius Medical raised $10M on March 4, 2025

Investors: NextGen Ventures, Invest-NL and + 5 Other investors

FAQ